
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.13 | 3.13 | 0.00 |
Shares | 96.87 | 96.87 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.61 | 18.77 |
Price to Book | 3.76 | 4.27 |
Price to Sales | 1.34 | 2.29 |
Price to Cash Flow | 12.87 | 15.61 |
Dividend Yield | 1.72 | 1.18 |
5 Years Earnings Growth | 8.99 | 11.14 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.73 | 99.59 |
Consumer Defensive | 0.19 | 0.49 |
Financial Services | 0.06 | 0.73 |
Industrials | 0.01 | 0.01 |
Technology | 0.01 | 0.17 |
Number of long holdings: 419
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 10.65 | 812.69 | +0.90% | |
AbbVie | US00287Y1091 | 4.99 | 190.28 | -0.29% | |
UnitedHealth | US91324P1021 | 4.95 | 281.06 | +0.89% | |
J&J | US4781601046 | 4.70 | 168.30 | -0.74% | |
Abbott Labs | US0028241000 | 4.15 | 126.54 | +0.72% | |
Intuitive Surgical | US46120E6023 | 3.55 | 495.86 | +1.48% | |
Merck&Co | US58933Y1055 | 3.47 | 84.71 | +0.71% | |
Boston Scientific | US1011371077 | 2.79 | 106.14 | -0.07% | |
Amgen | US0311621009 | 2.78 | 306.58 | -0.64% | |
Thermo Fisher Scientific | US8835561023 | 2.73 | 478.32 | +0.69% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Total Stock Market Ins Pls | 786.34B | 5.65 | 19.05 | 12.92 | ||
Vanguard 500 Index Admiral | 586.6B | 6.18 | 19.66 | 13.60 | ||
Vanguard Total Stock Market Admiral | 418.7B | 5.63 | 19.02 | 12.90 | ||
Vanguard Total Intl Stock Index Inv | 234.25B | 18.19 | 13.73 | 6.21 | ||
Vanguard 500 Index Institutional Se | 218.06B | 6.20 | 19.70 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review